BRCA2 gene: A candidate for clinical testing in familial colorectal cancer type X

Clinical Genetics

Volumn 87, Issue 6, 2015, Pages 582-587

  Garre, P ^a   Martin L ^a   Sanz, J ^a   Romero, A ^a   Tosar, A ^a   Bando, I ^a   Llovet, P ^a   Diaque, P ^a   Garcia Paredes B ^a   Diaz Rubio E ^a   de la Hoya, M ^a   Caldes T ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

BRCA2; Cancer susceptibility; Familial colorectal cancer; Risk alleles

Indexed keywords

BRCA2 PROTEIN; DNA;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; DOMINANT INHERITANCE; EXON; FAMILY; FAMILY HISTORY; FRAMESHIFT MUTATION; GENE FREQUENCY; GENETIC SCREENING; GENETIC VARIABILITY; GENOME; GENOTYPE; HEREDITARY COLORECTAL CANCER; HEREDITARY COLORECTAL CANCER TYPE X; HETEROZYGOSITY LOSS; HETEROZYGOTE; HUMAN; INTESTINE CANCER; INTRON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVARY CANCER; PENETRANCE; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; SEGREGATION ANALYSIS; SIBLING; TUMOR SUPPRESSOR GENE; VERY ELDERLY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GERMLINE MUTATION; MUTATION; PEDIGREE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; BRCA2 PROTEIN; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FAMILY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; GERM-LINE MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84928765929     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12427     Document Type: Article

References (16)

1. Vasen HF, Watson P, Mecklin JP et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999: 116: 1453-1456.
2. Garre P, Martin L, Bando I et al. Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer. Fam Cancer 2013: 13: 109-119.
3. Garre P, Briceno V, Xicola RM et al. Analysis of the oxidative damage repair genes NUDT1, OGG1, and MUTYH in patients from mismatch repair proficient HNPCC families (MSS-HNPCC). Clin Cancer Res 2011: 17: 1701-1712.
4. Palles C, Cazier JB, Howarth KM et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 2013: 45: 136-144.
5. Lefevre JH, Bonilla C, Colas C et al. Role of rare variants in undetermined multiple adenomatous polyposis and early-onset colorectal cancer. J Hum Genet 2012: 57: 709-716.
6. Daley D, Lewis S, Platzer P et al. Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study. Am J Hum Genet 2008: 82: 723-736.
7. Phelan CM, Iqbal J, Lynch HT et al. Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study. Br J Cancer 2014: 110: 530-534.
8. Caldes T, Godino J, Sanchez A et al. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep 2004: 12: 621-629.
9. Caldes T, Godino J, de la Hoya M et al. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Int J Cancer 2002: 98: 774-779.
10. Sanchez de Abajo A, de la Hoya M, Tosar A et al. Low prevalence of germline hMSH6 mutations in colorectal cancer families from Spain. World J Gastroenterol 2005: 11: 5770-5776.
11. Kote-Jarai Z, Leongamornlert D, Saunders E et al. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer 2011: 105: 1230-1234.
12. Osorio A, de la Hoya M, Rodriguez-Lopez R et al. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 2002: 99: 305-309.
13. Willems AJ, Dawson SJ, Samaratunga H et al. Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. Clin Cancer Res 2008: 14: 2953-2961.
14. Pettigrew CA, Wayte N, Wronski A et al. Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants. Breast Cancer Res Treat 2008: 110: 227-234.
15. Sliwinski T, Krupa R, Majsterek I et al. Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res Treat 2005: 94: 105-109.
16. Johnson N, Fletcher O, Palles C et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. Hum Mol Genet 2007: 16: 1051-1057.